Securities Class Actions – Page 31 – ClaimsFiler

Case Type: Securities Class Actions

On February 22, 2022, MP Materials Corp. was sued for violations of the federal securities laws in the United States District Court for the District of Nevada on behalf of investors who purchased the Company’s securities between May 1, 2020 and February 2, 2022.

On February 22, 2022, Gatos Silver, Inc. was sued for violations of the federal securities laws in the United States District Court for the District of Colorado on behalf of investors who purchased the Company’s securities between October 28, 2020 and January 25, 2022, inclusive (the “Class Period”) and/or purchased or otherwise acquired the Company’s shares pursuant to the Company’s October 2020 initial public offering (the “IPO”).

On February 16, 2022, Pulse Biosciences was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased the Company’s securities between January 12, 2021 and February 7, 2022.

On February 16, 2022, SunPower Corporation was sued for violations of the federal securities laws in the United States District Court for the Northern District of California on behalf of investors who purchased the Company’s securities between August 3, 2021 and January 20, 2022.

On February 16, 2022, Butterfly Network was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of investors who purchased or otherwise acquired Butterfly securities between February 16, 2021 and November 15, 2021, both dates inclusive (the “Class Period”), and/or (b) all holders of Butterfly common stock as of the record date for the special meeting of shareholders held on February 12, 2021 to consider approval of the merger between Longview and Butterfly (the “Merger”) and entitled to vote on the Merger (the “Class”).

On February 15, 2022, Acutus Medical, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of California on behalf of investors who purchased the Company’s shares between May 13, 2021 and November 11, 2021.

On February 9, 2022, Astra Space Inc. f/k/a Holicity Inc. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased the Company’s securities between February 2, 2021 and December 29, 2021.

On February 9, 2022, Fennec Pharmaceuticals was sued for violations of the federal securities laws in the United States District Court for the Middle District of North Carolina on behalf of investors who purchased the Company’s securities between May 28, 2021 and November 26, 2021.

On December 22, 2021, DocuSign was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased the Company’s securities between March 27, 2020 and December 2, 2021.

On February 7, 2022, Biogen was sued for violations of the federal securities laws in the United States District Court for the District of Massachusetts on behalf of investors who purchased the Company’s shares between November 19, 2020 and November 12, 2021.

On February 7, 2022, Telos Corporation was sued for violations of the federal securities laws in the United States District Court for the Eastern District of Virginia on behalf of investors who purchased the Company’s securities between March 31, 2021 and February 1, 2022.

On February 4, 2022, TAL Education Group was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased or otherwise acquired the Company’s American depository shares ("ADS") between April 26, 2018 and July 22, 2021.

On February 3, 2022, Electric Last Mile Solutions, Inc. f/k/a Forum Merger III Corp. was sued for violations of the federal securities laws in the United States District Court for the District of New Jersey on behalf of investors who purchased the Company’s securities between March 31, 2021 and February 1, 2022.

On January 31, 2022, Shattuck Labs was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased the Company’s securities between October 9, 2020 and November 9, 2021, inclusive (the “Class Period”) and/or pursuant and/or traceable to the Company's October 2020 initial public offering.

On January 27, 2022, Standard Lithium Ltd. was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased the Company’s securities between May 19, 2020 and November 17, 2021.

On January 24, 2022, Bumble Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of New York on behalf of investors who purchased shares pursuant or traceable to the Company’s Registration Statement issued in connection with the Company’s September 2021 secondary public stock (the "SPO" or the "Offering").

On January 24, 2022, Clarivate Plc was sued for violations of the federal securities laws in the United States District Court for the Eastern District of New York on behalf of investors who purchased the Company’s securities between February 26, 2021 and December 27, 2021.

On January 18, 2022, NRx Pharmaceuticals was sued for violations of the federal securities laws in the United States District Court for the District of Delaware on behalf of investors who purchased the Company’s securities between June 1, 2021 and November 4, 2021.

On January 14, 2022, FirstCash was sued for violations of the federal securities laws in the United States District Court for the Northern District of Texas on behalf of investors who purchased the Company’s shares between February 1, 2018 and November 12, 2021.

We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.

OK